ArticleFrontiers in cardiovascular medicine2026
Disparities in obesity-related cardiovascular-induced mortality trends in the U.S. of America over two decades.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular disease (CVD) remains the leading cause of death in the U.S., and the growing prevalence of obesity has amplified this burden. Despite extensive research on their pathophysiologic interplay, long-term mortality trends among adults with both conditions remain insufficiently characterized. Methods: Using national death certificate data from the CDC WONDER database (1999-2020), we examined age-adjusted mortality rates (AAMRs) for CVD with obesity listed as a contributing cause among adults aged ≥25 years. Temporal trends were analyzed using joinpoint regression to estimate annual percent change (APC) and average annual percent change (AAPC) with 95% confidence intervals, stratified by sex, ethnicity, census region, state, and urbanization level. Results: From 1999 to 2020, the national AAMR increased steadily across all subgroups. Males had higher mortality and a steeper rise than females (AAPC 5.94% vs. 4.40%), with female rates accelerating after 2018. Non-Hispanic Black (NH Black) adults consistently experienced the highest mortality, while Hispanic and NH Black populations exhibited the sharpest recent increases. The South and Midwest regions showed the fastest growth (AAPC >5%), and nonmetropolitan areas surpassed metropolitan ones (AAPC 5.69% vs. 4.98%). Oklahoma displayed the most pronounced escalation nationwide (AAPC 10.52%). Conclusions: Over two decades, obesity-related CVD mortality has risen markedly and unevenly across demographic and geographic lines in the U.S. These findings highlight the intensifying intersection of cardiometabolic disease and social inequity, underscoring the urgent need for equity-centered prevention and investment in vulnerable communities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.